Physician profile
Daniel Gonzalez
NPI 1336672716
$1,646.46
in general payments reported to CMS, 2019-2025
11 companies · $93.97 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.96 · 2021: $84.37 · 2022: $125 · 2023: $1,167 · 2024: $153 · 2025: $93.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.78 | 2021-2023 | |
| Shockwave Medical, INC | $257.31 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Incyte Corporation | $249.50 | 2022-2023 | Opzelura |
| Depuy Synthes Sales INC. | $142.85 | 2023 | Monovisc |
| Atricure, INC. | $128.48 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.69 | 2023 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $121.97 | 2023 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $120.80 | 2023 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $105.88 | 2023 | Ilumya |
| Boston Scientific Corporation | $40.24 | 2021-2025 | Versacross Access Solution |
| Alexion Pharmaceuticals, INC. | $22.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.